UKIPO issues formal response to Industrial Strategy IP views
22-05-2018
Regeneron forms consortium to fund exome sequencing
12-01-2018
UK government announces life sciences deal; GSK and AstraZeneca invest
11-12-2017
MSD, known as Merck and Co in the US and Canada, announced plans to launch a life sciences discovery research facility just hours ahead of the UK government’s release of its industrial strategy.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
UK government, life sciences, industrial strategy, Merck Sharpe Dohme, MSD, innovation, research
